Delivery Order SPE2DB20D2104-SPE2DB22FR64F
- Not listed
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order, valued at $1,848.86, is for the supply of Oxycontin ER 20 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,806.50, is for the delivery of Oxycontin ER 40 mg tablets in quantities of 100s. This is a firm fixed-price Delivery Order contract with a period of performance through March 11, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $1,730.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, covers the supply of Oxycontin ER 30 mg tablets. This pharmaceutical product falls under the broader scope of the DLA's IDC with AmerisourceBergen, which is valued at...
- This federal contract award, valued at $1,660.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Oxycontin ER 20 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of July 18, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded multiple indefinite delivery contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,850,528 Oxycontin ER 10 mg tablets in 100-count bottles. The $1,377.50 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) on June 7, 2024, with a completion date of June 10, 2024. This award does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a substantial Indefinite Delivery Contract (IDC) valued...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office division is for the delivery of 4,565,059,472 OxyContin ER 40 mg tablets in 100-count packages. The $2,444.93 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on July 2, 2024, with a completion date of July 3, 2024. This award is made under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025,...
- This federal contract award, valued at $7,577.70, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of Oxycontin ER 40 mg tablets, with a completion date of June 24, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The...
- This federal contract award, valued at $1,266.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of OxyContin ER 10 mg tablets, with a performance period through March 2025. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,129.77, is for the delivery of 4567829172 Oxycontin ER 80 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Oxycontin ER 20 mg tablets. The $6,699.40 Firm Fixed Price Delivery Order contract has an ultimate completion date of July 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR64FDelivery Order
This federal contract award, valued at $11,620.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,556,062,609 Oxycontin ER 40 mg tablets, with a completion date of January 27, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation, indicating it was awarded through full and open competition. The parent company of AmerisourceBergen Drug Corp is Cencora, Inc., which also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 1/26/22 |